| Developers: | NRNU MEPhI - National Research Nuclear University MEPhI |
| Date of the premiere of the system: | 2024/02/14 |
| Branches: | Pharmaceuticals, Medicine, Healthcare |
Main article: Cancer diagnosis
2024: Gamma Ray Locator Development
A team led by Philip Dubinin, senior lecturer at the Department of Particle Physics at NRNU MEPhI, has developed a gamma locator - a device for finding and localizing malignant neoplasms. The university announced this on February 14, 2024.
When developing breast tumors cancer , cells can enter the lymphatic system. In this case, they accumulate in the lymph node closest to the tumor - such a lymph node is called signaling.
Before the operation to remove the tumor, a pharmaceutical product marked with an isotope is introduced into the patient's body. After removal of the main tumor, the gamma locator allows you to quickly and accurately detect the place of accumulation of the radiopharmaceutical - the signal lymph node. This helps the surgeon localize residual tumor tissue and radically reduce the risk of damage to healthy tissues.
 | Our device has a long history: nine years ago a pre-production sample appeared, which was distributed to several clinics for testing, - said Philip Dubinin. - Since then, the device has been refined several times, and now it is fully prepared for certification. |  |
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |